ArticleCancers2023

AFP Response to Locoregional Therapy Can Stratify the Risk of Tumor Recurrence in HCC Patients after Living Donor Liver Transplantation.

I-Hsuan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.